Clinical Trial Update: Do QT-Prolonging Drugs Cause Major Adverse Cardiac Events in Hospitalized Adults?

View source ↗

Summary

A recruiting clinical trial assessing whether drugs that prolong the QT interval lead to major adverse cardiac events in hospitalized adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Long Qt Syndrome
• Syncope
• Torsades De Pointes
• Ventricular Arrhythmias

Snippet

Sponsor: St. Joseph's Healthcare Hamilton | Conditions: Acquired Long QT, Ventricular Arrhythmias | Status: RECRUITING